Browdy and Neimark, P.L.L.C.
Patent reexamination counsel·3 ex parte reexams
Browdy and Neimark, P.L.L.C. has served as patent-owner counsel in 3 USPTO ex parte reexaminations. The firm most often represents Tova Waks and Cell Genesys Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners represented
Outcome track record
How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.
- Certificate outcome split across every bucket
- Share of proceedings where claims survived
Practice metrics
Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.
- Certificate rate of closed proceedings
- Average pendency in months
Examiners & adversaries
Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.
- Most frequent examiners
- Top opposing requesters
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/013,790 | Aug 5, 2016 | 7,741,465 | Chimeric Receptor Genes and Cells Transformed Therewith | Tova Waks | Closed |
| 90/013,703 | Mar 18, 2016 | 6,319,494 | Chimeric Chains for Receptor-Associated Signal Transduction Pathways | Cell Genesys Inc. | Closed |
| 90/013,630 | Nov 16, 2015 | 7,741,465 | Chimeric Receptor Genes and Cells Transformed Therewith | Tova Waks | Closed |
Other reexam law firms
See the full reexam picture for Browdy and Neimark, P.L.L.C.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.